Functional Differences in Engineered Myocardium from Embryonic Stem Cell-Derived versus Neonatal Cardiomyocytes
Adam W. Feinberg(Carnegie Mellon University), Kevin Kit Parker(Boston Children's Hospital), Crystal M. Ripplinger(University of California, Davis), Sean P. Sheehy(Harvard University), Ibrahim J. Domian(Harvard University), Peter van der Meer(University Medical Center Groningen), Kenneth R. Chien(Karolinska Institutet)
Cited by 49
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing
|Nature Materials|2016|845
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
|Nature Medicine|2014|843
Muscular Thin Films for Building Actuators and Powering Devices
|Science|2007|765
Nanowired three-dimensional cardiac patches
|Nature Nanotechnology|2011|759